Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;2(2):425-33.
doi: 10.2147/opth.s736.

Current and future approaches in the prevention and treatment of diabetic retinopathy

Louis K Chang  1 , David Sarraf
Affiliations
Free PMC article

Current and future approaches in the prevention and treatment of diabetic retinopathy

Louis K Chang et al. Clin Ophthalmol. 2008 Jun.
Free PMC article

Abstract

Diabetic retinopathy (DR) is a major cause of blindness worldwide and is the number one cause of blindness in working-age individuals in developed countries. We review the current literature and discuss the pathogenesis, modifying risk factors, genetics, and treatment of DR. Special focus is placed on the rationale and effectiveness of therapeutic modalities, both current and future.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Management of Type 1 Diabetes in Pregnancy.
    Feldman AZ, Brown FM. Feldman AZ, et al. Curr Diab Rep. 2016 Aug;16(8):76. doi: 10.1007/s11892-016-0765-z. Curr Diab Rep. 2016. PMID: 27337958 Free PMC article. Review.
  • Editorial foreword.
    Fraser SG. Fraser SG. Clin Ophthalmol. 2008 Jun;2(2):i-ii. Clin Ophthalmol. 2008. PMID: 19668711 Free PMC article. No abstract available.

References

    1. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445–50. - PubMed
    1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7. - PubMed
    1. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997;46:1473–80. - PubMed
    1. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol. 2002;47(Suppl 2):S263–269. - PubMed
    1. Aiello LP, Davis MD, Girach A, et al. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology. 2006;113:2221–30. - PubMed

LinkOut - more resources